Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Operating Leases (2019 - 2025)

Medifast (MED) has disclosed Operating Leases for 7 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 38.74% year-over-year to $6.1 million, compared with a TTM value of $6.1 million through Dec 2025, down 38.74%, and an annual FY2025 reading of $6.1 million, down 38.74% over the prior year.
  • Operating Leases was $6.1 million for Q4 2025 at Medifast, down from $6.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $29.3 million in Q2 2022 and bottomed at $6.1 million in Q4 2025.
  • Average Operating Leases over 5 years is $16.8 million, with a median of $15.8 million recorded in 2021.
  • The sharpest move saw Operating Leases surged 269.21% in 2022, then tumbled 41.05% in 2025.
  • Year by year, Operating Leases stood at $26.0 million in 2021, then dropped by 22.08% to $20.3 million in 2022, then fell by 20.46% to $16.1 million in 2023, then tumbled by 38.35% to $9.9 million in 2024, then tumbled by 38.74% to $6.1 million in 2025.
  • Business Quant data shows Operating Leases for MED at $6.1 million in Q4 2025, $6.8 million in Q3 2025, and $13.1 million in Q2 2025.